• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Tao Synergies Inc.

    8/14/25 4:19:26 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $TAOX alert in real time by email

    Unavailable

    Get the next $TAOX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TAOX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TAOX
    SEC Filings

    View All

    SEC Form D filed by Tao Synergies Inc.

    D - TAO Synergies Inc. (0001571934) (Filer)

    10/24/25 4:12:47 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tao Synergies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - TAO Synergies Inc. (0001571934) (Filer)

    10/14/25 6:12:21 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tao Synergies Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - TAO Synergies Inc. (0001571934) (Filer)

    8/29/25 5:00:44 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TAOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Weinstein Robert covered exercise/tax liability with 4,000 shares and was granted 10,000 shares, increasing direct ownership by 57% to 16,574 units (SEC Form 4)

    4 - TAO Synergies Inc. (0001571934) (Issuer)

    10/17/25 5:14:09 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Singer William S. was granted 15,000 shares and covered exercise/tax liability with 6,000 shares, increasing direct ownership by 85% to 19,566 units (SEC Form 4)

    4 - TAO Synergies Inc. (0001571934) (Issuer)

    10/17/25 5:13:16 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Executive Chairman Silverman Joshua was granted 100,000 shares and covered exercise/tax liability with 40,000 shares, increasing direct ownership by 225% to 86,681 units (SEC Form 4)

    4 - TAO Synergies Inc. (0001571934) (Issuer)

    10/17/25 5:12:16 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TAOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency

    NEW YORK, Oct. 20, 2025 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) ("TAO Synergies" or the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (DeAI), today announced that through acquisition and staking, the Company's total TAO holdings have increased to 54,058 tokens. This further solidifies TAO Synergies' position as the largest publicly traded pure-play holder of Bittensor (TAO), the groundbreaking protocol powering decentralized AI innovation. TAO Synergies continues to execute on its mission to democratize access to decentralized AI for retail and institutional investors alike, while capturin

    10/20/25 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TAO Synergies Announces $11 Million Private Placement

    Financing supported by existing stockholders, TAO Strategy Advisor James Altucher, and new investor DCG NEW YORK, Oct. 13, 2025 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) (the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (DeAI), today announced that it has entered into a securities purchase agreement with existing investors, James Altucher and a new investor, DCG, for a $11 million financing. "TAO Synergies' latest financing further supports its continuing strategic investments not only in TAO tokens, but also in potential opportunities to earn revenue and accrue additional TAO within the Bi

    10/13/25 5:09:00 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)

    New digital hub to educate, engage, and connect the growing TAO community and decentralized AI contributors NEW YORK, Sept. 22, 2025 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) (the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (DeAI), today announced the launch of "The Tao Daily," a comprehensive media, news, and insight platform dedicated to Bittensor (TAO) and the TAO ecosystem.  The TAO Daily is designed not only to be up to date on all news related to TAO, but also to educate the market about the Bittensor ecosystem, its native token TAO, and the specialized subnets within the TAO network

    9/22/25 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TAOX
    Financials

    Live finance-specific insights

    View All

    TAO Synergies Acquires $10 Million of Bittensor (TAO) to Become Largest Publicly Traded Pure Play TAO Holder

    29,899 TAO tokens purchased to date Stakes tokens in decentralized AI network for yield generation NEW YORK, July 17, 2025 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) (the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (AI), today announced that as of July 17, 2025, it has acquired 29,899 TAO tokens for a total purchase price of $10.0 million, at an average price of approximately $334 per token. The purchases of TAO are in accordance with the Company's digital asset treasury strategy directed toward TAO, the native token for Bittensor, a decentralized AI network that incentivizes the development

    7/17/25 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care